Cargando…
The changing role of radiation therapy in the management of oligometastatic disease
It is clear from surgical series that there are selected patients presenting with localised metastatic disease who can be cured by radical ablation of the metastasis. To date this has been limited to surgical resection but the evolution of stereotactic ablative body radiotherapy (SABR) has opened ne...
Autores principales: | Tharmalingham, H., Hoskin, P.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033765/ https://www.ncbi.nlm.nih.gov/pubmed/32095538 http://dx.doi.org/10.1016/j.tipsro.2017.01.001 |
Ejemplares similares
-
First multicentre experience of SABR for lymph node and liver oligometastatic disease on the unity MR-Linac
por: Janssen, Tomas M., et al.
Publicado: (2022) -
Exploring opportunities & pathways for advanced practice radiation therapy roles in the United States
por: Skubish, Samantha, et al.
Publicado: (2021) -
The impact of bladder preparation protocols on post treatment toxicity in radiotherapy for localised prostate cancer patients
por: Tsang, Yat Man, et al.
Publicado: (2017) -
Automatic localization of the prostatic urethra for image guided radiation therapy
por: Nasser, Nicola J., et al.
Publicado: (2021) -
Implementation of an in‐house visual feedback system for motion management during radiation therapy
por: Nguyen, Vi Nhan V., et al.
Publicado: (2016)